Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company’s web site at www.sequenom.com.
- 18 years ago
QualityStocks
Sequenom, Inc. (NASDAQ: SQNM)
Tags Rodman & Renshaw
Related Post
-
Mobilicom Ltd. (NASDAQ: MOB) Builds on $2.2 Million in Orders with Pipeline of Nine Tier-1 Design Wins Globally
Late last year, the Pentagon launched a $1 billion drone dominance program, with U.S. Secretary…
-
Gold Prices Rebound with Democratic Midterm Sweep In US
Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising. LaFleur Minerals Inc.…
-
Barry Ritholtz Joins Howard Lindzon to Open the Stocktoberfest 2026 Programming Day
The programming day of Stocktoberfest presented by Tradr ETFs opened on October 7 at City…